Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия; 2 ГБУЗ «Городская клиническая больница им. С.С. Юдина» Департамента здравоохранения г. Москвы, Москва, Россия dvoretski@mail.ru
Список исп. литературыСкрыть список 1. Knight M, Nelson-Piercy C, Spark P, Brocklehurst P. UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57 (7): 951–6. 2. Goel A, Eapen CE, Mathews J. Contribution of pregnancy related liver diseases to maternal mortality at Vellore. Indian J Gastroenterol 2007; 26 (Suppl. 2): A83. 3. Bellig LL. Maternal acute fatty liver of pregnancy and the associated risk for deficiency in infants. Adv Neonatal Care 2004; 4 (1): 26–32. DOI: 10.1016/j.adnc.2003.12.001 4. Ibdah JA, Bennett MJ, Rinaldo P et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340 (22): 1723. 5. Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol 2016; 111 (2): 176. 6. Yang Z, Yamada J, Zhao Y et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002; 288 (17): 2163. 7. Rector RS, Ibdah JA. Fatty acid oxidation disorders: maternal health and neonatal outcomes. Semin Fetal Neonatal Med 2010; 15 (3): 122. 8. Bacq Y, Assor P, Gendrot C et al. Andres C. Recurrent acute fatty liver of pregnancy. Gastroenterol Clin Biol 2007; 31 (12): 1135. 9. Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis 2010; 33 (5): 527. 10. Ellington SR, Flowers L, Legardy-Williams JK et al. Recent trends in hepatic diseases during pregnancy in the United States, 2002–2010. Am J Obstet Gynecol 2015; 212 (4): 524.e1-7. 11. Игнатова Т.М. Печень и беременность. Клиническая гепатология. 2008; 2. [Ignatova T.M. Pechen' i beremennost'. Klinicheskaia gepatologiia. 2008; 2 (in Russian).] 12. Ch’ng CL, Morgan М, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51: 876–80. 13. Goel A, Ramakrishna B, Zachariah U et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? Gut 2011; 60: 138. 14. Liu J, Ghaziani TT, Wolf JL. Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management. Am J Gastroenterol 2017; 112: 838. 15. Hin Hin Ko, Eric Yoshida. Acute fatty liver of pregnancy. Can J Gastroenterol 2006; 20 (1): 25–30. 16. Morton А, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstetric Medicine 2018; 11 (3): 126–31. 17. Стрижаков А.Н., Игнатко И.В., Тимохина Е.В. и др. Острая жировая дистрофия печени у беременных: клинико-диагностические контраверсии, осложнения и прогноз. Вопросы гинекологии, акушерства и перинатологии. 2019; 18 (3): 133–39. DOI: 10.20953/1726-1678-2019-3-133-139 [Strizhakov A.N., Ignatko I.V., Timokhina E.V. et al. Ostraia zhirovaia distrofiia pecheni u beremennykh: kliniko-diagnosticheskie kontraversii, oslozhneniia i prognoz. Voprosy ginekologii, akusherstva i perinatologii. 2019; 18 (3): 133–39. DOI: 10.20953/1726-1678-2019-3-133-139 (in Russian).]